These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19688972)

  • 1. Three-dimensional conformal radiotherapy, temozolomide chemotherapy, and high-dose fractionated stereotactic boost in a protocol-driven, postoperative treatment schedule for high-grade gliomas.
    Pirtoli L; Rubino G; Marsili S; Oliveri G; Vannini M; Tini P; Miracco C; Santoni R
    Tumori; 2009; 95(3):329-37. PubMed ID: 19688972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and safety of 3-dimensional conformal radiotherapy combined with temozolomide for glioma].
    Wang L; Tu Q; Zhou W; Zhou R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1106-10. PubMed ID: 22169729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report.
    Balducci M; Apicella G; Manfrida S; Mangiola A; Fiorentino A; Azario L; D'Agostino GR; Frascino V; Dinapoli N; Mantini G; Albanese A; de Bonis P; Chiesa S; Valentini V; Anile C; Cellini N
    Strahlenther Onkol; 2010 Oct; 186(10):558-64. PubMed ID: 20936460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas.
    Minniti G; Scaringi C; De Sanctis V; Lanzetta G; Falco T; Di Stefano D; Esposito V; Enrici RM
    J Neurooncol; 2013 Jan; 111(2):187-94. PubMed ID: 23129347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-brain irradiation with concomitant daily fixed-dose temozolomide for brain metastases treatment: a randomised phase II trial.
    Gamboa-Vignolle C; Ferrari-Carballo T; Arrieta Ó; Mohar A
    Radiother Oncol; 2012 Feb; 102(2):187-91. PubMed ID: 22257825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temozolomide during and after radiation therapy for WHO grade III gliomas: preliminary report of a prospective multicenter study.
    Kim YH; Park CK; Cho WH; Kim IA; Moon S; Choe G; Park SH; Kim IH; Kim DG; Jung HW; Lee MM; Bae SH; Cha SH; Kim CY
    J Neurooncol; 2011 Jul; 103(3):503-12. PubMed ID: 20862518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temozolomide and radiotherapy as first-line treatment of high-grade gliomas.
    Corsa P; Parisi S; Raguso A; Troiano M; Perrone A; Cossa S; Munafò T; Piombino M; Spagnoletti G; Borgia F
    Tumori; 2006; 92(4):299-305. PubMed ID: 17036520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The outcomes of concomitant radiation plus temozolomide followed by adjuvant temozolomide for newly diagnosed high grade gliomas: the preliminary results of single center prospective study.
    Shawky H; Abo Hamar AH; Galal S; Zakaria F; El-Shorbagy D
    J Egypt Natl Canc Inst; 2009 Jun; 21(2):107-19. PubMed ID: 21057562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide in paediatric high-grade glioma: a key for combination therapy?
    Verschuur AC; Grill J; Lelouch-Tubiana A; Couanet D; Kalifa C; Vassal G
    Br J Cancer; 2004 Aug; 91(3):425-9. PubMed ID: 15266331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma.
    Minniti G; Armosini V; Salvati M; Lanzetta G; Caporello P; Mei M; Osti MF; Maurizi RE
    J Neurooncol; 2011 Jul; 103(3):683-91. PubMed ID: 21052773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
    Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
    J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
    Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
    Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas.
    Combs SE; Bischof M; Welzel T; Hof H; Oertel S; Debus J; Schulz-Ertner D
    J Neurooncol; 2008 Sep; 89(2):205-10. PubMed ID: 18461281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade gliomas: results in patients treated with adjuvant radiotherapy alone and with adjuvant radio-chemotherapy.
    Valeriani M; Ferretti A; Franzese P; Tombolini V
    Anticancer Res; 2006; 26(3B):2429-35. PubMed ID: 16821628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas.
    Chamberlain MC
    Expert Rev Neurother; 2010 Oct; 10(10):1537-44. PubMed ID: 20925470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma.
    Jalali R; Raut N; Arora B; Gupta T; Dutta D; Munshi A; Sarin R; Kurkure P
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):113-8. PubMed ID: 19647954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiochemotherapy with temozolomide for patients with glioblastoma. Prognostic factors and long-term outcome of unselected patients from a single institution.
    Gerstein J; Franz K; Steinbach JP; Seifert V; Rödel C; Weiss C
    Strahlenther Onkol; 2011 Nov; 187(11):722-8. PubMed ID: 22037649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study.
    Balducci M; D'Agostino GR; Manfrida S; De Renzi F; Colicchio G; Apicella G; Mangiola A; Fiorentino A; Frascino V; Mantini G; De Bari B; Pompucci A; Valentini V; Anile C; Cellini N
    J Neurooncol; 2010 Mar; 97(1):95-100. PubMed ID: 19705066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.
    Perry JR; Bélanger K; Mason WP; Fulton D; Kavan P; Easaw J; Shields C; Kirby S; Macdonald DR; Eisenstat DD; Thiessen B; Forsyth P; Pouliot JF
    J Clin Oncol; 2010 Apr; 28(12):2051-7. PubMed ID: 20308655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.